Molecular Hallmarks of Prostate-specific Membrane Antigen in Treatment-naïve Prostate Cancer

By sjmartinez • September 19, 2024

Weiner AB, Agrawal R, Wang NK, Sonni I, Li EV, Arbet J, Zhang JJH, Proudfoot JA, Hong BH, Davicioni E, Kane N, Valle LF, Kishan AU, Pra AD, Ghadjar P, Sweeney CJ, Nickols NG, Karnes RJ, Shen J, Rettig MB, Czernin J, Ross AE, Lee Kiang Chua M, Schaeffer EM, Calais J, Boutros PC, Reiter RE. Molecular Hallmarks of Prostate-specific Membrane Antigen in Treatment-naïve Prostate Cancer. Eur Urol. 2024 Sep 17:S0302-2838(24)02597-1. doi: 10.1016/j.eururo.2024.09.005. Epub ahead of print. PMID: 39294048.

Tags: biomarkers, Cardiology/Epi, gene expression, Gene Expression Profiling, Hematology/Oncology, humans, prognosis, Prostatic neoplasms/genetics, Prostatic neoplasms/pathology, Publications, tumor, Veterans Administration

An implantable wireless battery-free spatially selective vagus nerve stimulator

Rutkovskis E, Ravagli E, Lancashire HT, Shah Idil A, Thompson N, Perkins JD, Challita R, Hadaya J, Vivekananda U, Ajijola O, Shivkumar K, Miserocchi A,[...]

Long-Term Outcomes of Contemporary Balloon-Expandable TAVR in Bicuspid Aortic Valve: A Propensity-Matched Comparison to Tricuspid

Suruga K, Patel V, Shitan H, Yuchao G, Nagasaka T, Ng D, Menda J, Singh A, Goyal A, Buss E, Kremenovic A, Dermand E, Jain[...]

The latest Fontan paradox: when less is more (difficult)

Moore JP, Paul T, Etheridge SP. The latest Fontan paradox: when less is more (difficult). Europace. 2026 Sep 2;28(9):euag239. doi: 10.1093/europace/euag239. PMID: 42732894; PMCID: PMC13571844.